Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human LIF ELISA Kit (AC3523)
Cat.#: ASET-2112
Specifications
Description Human LIF ELISA Kit allows for the in vitro quantitative determination of human LIF concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 18.75 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 31.25-2000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1355 Human Prion Protein PrP ELISA Kit (AC2766) Quantitative inquiry ASET-1043 Mouse Glypican 4 ELISA Kit (AC2454) Quantitative inquiry ASET-1543 Mouse TRPV1 ELISA Kit (AC2954) Quantitative inquiry ASET-2314 Human TNF Receptor II ELISA Kit (AC3725) Quantitative inquiry ASET-1283 Human Malondialdehyde ELISA Kit (AC2694) Quantitative inquiry ASET-1295 Human NPFF2 Receptor ELISA Kit (AC2706) Quantitative inquiry ASET-2095 Rat Dopamine D2 Receptor ELISA Kit (AC3506) Quantitative inquiry ASET-1504 Human beta Catenin ELISA Kit (AC2915) Quantitative inquiry ASET-1451 Human PSPN ELISA Kit (AC2862) Quantitative inquiry ASET-1827 Mouse CRF ELISA Kit (AC3238) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket